Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kaigen Pharma Co., Ltd. is a Japanese pharmaceutical and medical device company headquartered in Osaka, operating as a subsidiary of Nipro Corporation. The company was established in 2013 following the merger of Kaigen Co., Ltd. and the pharmaceutical business of Kyowa Hakko Kirin. Kaigen Pharma specializes in gastroenterology, offering a comprehensive portfolio that includes gastrointestinal diagnostic agents, endoscopic equipment, and proteolytic enzymes like Pronase. Additionally, the company maintains a significant presence in the consumer healthcare market with its long-standing Kaigen brand of over-the-counter cold medicines. Its business model integrates the development, manufacturing, and distribution of both therapeutic drugs and specialized medical devices for clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kaigen Pharma.